Can Mounjaro affect your periods?

Why your period might change when you start Mounjaro

A question our prescribers hear most weeks is whether Mounjaro can make periods irregular. The honest answer is: probably not by acting directly on the uterus, but possibly through several knock-on effects that are well understood in medicine.

The most straightforward mechanism is weight loss itself. Fat tissue produces and stores oestrogen. When body weight falls relatively quickly, circulating oestrogen levels can drop, and the hypothalamic-pituitary-ovarian axis (the hormonal feedback loop that regulates your cycle) may temporarily recalibrate. This is the same reason some women notice cycle changes after bariatric surgery or during rapid weight loss by other means. The NHS notes that weight changes can affect hormone levels and menstrual regularity, and tirzepatide produces some of the most significant weight reductions of any licensed medicine, so the effect can be more pronounced than with slower approaches.

Separately, improved insulin sensitivity matters here. Tirzepatide works as a dual GIP and GLP-1 receptor agonist, reducing insulin resistance alongside its appetite effects. For women with conditions like polycystic ovary syndrome (PCOS), where insulin resistance disrupts cycle regularity, that improvement in sensitivity can actually restore more regular ovulation. So the direction of change is not the same for everyone: some women find cycles become less regular, others find they become more so. You can read the tirzepatide clinical overview for more on how the medicine works at a biological level.

The contraceptive pill interaction you need to know about

This is the most practically important period-related fact about Mounjaro, and it is the one most worth acting on. Tirzepatide slows gastric emptying, which means oral medicines may pass through the gut more slowly, and their absorption can be affected. For oral contraceptive pills, NHS England's guidance on weight-management injections advises that women using oral contraceptives should add a non-oral method of contraception (such as condoms) for the first four weeks of Mounjaro treatment and for four weeks after each dose increase.

This is not a permanent change to your contraception plan. Once you are established on a stable dose, the interaction risk is lower. But if you miss that window, a reduced absorption of the pill could affect its effectiveness without any obvious sign. A secondary effect worth flagging: if ovulation resumes (for instance in women with PCOS who become more regularly fertile) the risk of unintended pregnancy increases. The guidance from NHS England is clear that effective contraception is important throughout treatment.

If you are on the pill and starting Mounjaro for the first time, raise this with your prescriber before your first injection. Our patient FAQs also cover this point in more detail.

Should you be concerned, or is this expected?

Deciding how to respond to a period change is the practical question most readers land here with. The short answer: mild irregularity in the first one to three months is common enough that many clinicians consider it an expected adjustment rather than a warning sign, particularly if weight loss has been substantial. Cycles often settle as the body acclimates.

That said, some changes do warrant a conversation rather than watchful waiting. Speak to your GP or prescriber if you experience: very heavy or prolonged bleeding that is new for you; a complete absence of periods for more than three months when you were previously regular; significant pain that is out of character; or any change you find worrying, regardless of whether it fits a pattern. These are not automatic red flags for a serious problem, but they deserve assessment rather than assumption.

It is also worth remembering that Mounjaro is prescribed alongside a reduced-calorie diet and increased activity. Both of those independently influence hormonal balance, so isolating the medicine as the sole cause of any change is rarely straightforward. Read more about the Mounjaro treatment overview for the wider clinical picture, and see our weight-loss treatment options page if you are still deciding which approach fits your situation. For cost context, the Mounjaro cost guide explains what private treatment typically involves.

How a clinical prescriber thinks about this before and during treatment

When a prescriber at a regulated pharmacy reviews a Mounjaro consultation, menstrual and reproductive history is part of the picture. Women who are pregnant, breastfeeding, or trying to conceive are not suitable candidates, Mounjaro is not licensed in those circumstances, and a prescriber will identify this at consultation stage. Similarly, a history of gynaecological conditions, current contraception method, and any fertility considerations are relevant to the prescribing decision and any follow-up advice.

The NHS medicines page for tirzepatide includes information on interactions and reproductive considerations, and is a reliable first reference. If you are mid-treatment and noticing cycle changes, you may find it helpful to read about whether Mounjaro can affect your period, explore the detail on how Mounjaro affects periods across different patients, or review the evidence on the ways Mounjaro can effect periods before speaking to your prescriber or GP about next steps. The clinical team at nume provides priority aftercare seven days a week, so questions that come up between doses have somewhere to go. Our clinical lead's profile is available at our clinical team page if you'd like to know more about who oversees patient care.

If you'd like to explore whether Mounjaro is clinically suitable for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.